The BRAIN Foundation and Stanford Medicine Launch Aurora Research Network to Advance Evidence-Based Care for Severe Neuropsychiatric Deterioration The BRAIN Foundation, in partnership with Stanford Medicine, has announced the launch…
Seek Labs Publishes Nature Communications Study Showcasing ANINA™ Technology for Next-Generation Molecular Diagnostics Seek Labs, a private TechBio company focused on developing programmable technologies to decode, understand, and treat disease,…
FUJIFILM Sonosite Launches Sonosite iLOOK, a Dedicated Ultrasound Solution Designed to Enhance Vascular Access Procedures FUJIFILM Sonosite, Inc., a global leader in point-of-care ultrasound (POCUS) technology, has announced the introduction…
Cellares and Papillon Therapeutics Partner to Automate Manufacturing of PPL-001 Gene-Edited Cell Therapy for Friedreich’s Ataxia Cellares, the world’s first Integrated Development and Manufacturing Organization (IDMO) dedicated to advancing cell…
Teleflex Awarded National Group Purchasing Agreement with Premier to Expand Access to Advanced Vascular Access Solutions Teleflex Incorporated, a global provider of medical technologies designed to improve patient care and…
Pilatus Biosciences Receives Hong Kong Clinical Trial Authorization for PLT012 and Expands Asia-Pacific Presence with New Regional Subsidiary Pilatus Biosciences, Inc., a clinical-stage biopharmaceutical company focused on developing innovative metabolic…
Restore Vision and Forge Biologics Partner to Advance RV-001 Gene Therapy for Retinitis Pigmentosa Through Clinical Development Restore Vision, Inc., a clinical-stage biotechnology company focused on developing innovative gene therapies…
Ashlins Pharmaceuticals Signs Exclusive Global Licensing Agreement with Lee’s Pharmaceutical Holdings to Advance Interferon Alpha-2b Drug Development Ashlins Pharmaceuticals has announced that its wholly owned subsidiary, Ashlins Ocular Pharmaceuticals, Inc.,…
Brenus Pharma Secures €11 Million Series A Extension to Advance Lead Cancer Immunotherapy and Expand Proprietary In Vivo Immunotherapy Platform Brenus Pharma has announced the successful completion of an €11…
LAPIX Therapeutics Completes Enrollment in Rheumatoid Arthritis Cohort of LPX-TI641 Clinical Trial, Advancing Development of First-in-Class Oral TIM 3/4 Agonist LAPIX Therapeutics, a clinical-stage biotechnology company focused on developing innovative…
Flashpoint Therapeutics Celebrates Founder Professor Chad A. Mirkin’s Selection for the 2027 ACS Priestley Medal Flashpoint Therapeutics, a biotechnology company focused on advancing next-generation nanomedicines, has announced that its founder,…
DivcoWest Announces Collegium Pharmaceutical as One Lincoln Tenant DivcoWest, a DivCore Capital company and a leading national commercial real estate investment firm, has announced that Collegium Pharmaceutical, a biopharmaceutical company…